Naoki Dozono
Nagasaki, 8528521, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Erratum to "A novel lysophosphatidic acid receptor 1 antagonist with high brain penetrability has a curative effect in the empathic pain-related fibromyalgia model" [J Pharmacol Sci (2025) 139-142].
Journal: Journal of pharmacological sciences
Published: May 07, 2025
A novel lysophosphatidic acid receptor 1 antagonist with high brain penetrability has a curative effect in the empathic pain-related fibromyalgia model.
Journal: Journal of pharmacological sciences
Published: February 06, 2025
Peripheral Beta-2 Adrenergic Receptors Mediate the Sympathetic Efferent Activation from Central Nervous System to Splenocytes in a Mouse Model of Fibromyalgia.
Journal: International journal of molecular sciences
Published: November 24, 2022
Secreted PLA2-III is a possible therapeutic target to treat neuropathic pain.
Journal: Biochemical and biophysical research communications
Published: May 27, 2021
Chronic generalized pain disrupts whole brain functional connectivity in mice.
Journal: Brain imaging and behavior
Published: December 20, 2020
Allodynia by Splenocytes From Mice With Acid-Induced Fibromyalgia-Like Generalized Pain and Its Sexual Dimorphic Regulation by Brain Microglia.
Journal: Frontiers in neuroscience
Published: September 07, 2020
Mirtazapine, an α2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 25, 2020
NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026